
Gregory A. Otterson, MD, discusses data examining immunotherapy alone versus in combination in non–small cell lung cancer.

Your AI-Trained Oncology Knowledge Connection!


Gregory A. Otterson, MD, discusses data examining immunotherapy alone versus in combination in non–small cell lung cancer.

Gregory A. Otterson, MD, discusses when to start treatment with immunotherapy in patients with non–small cell lung cancer.

Gregory A. Otterson, MD, discusses targetable biomarkers in non–small cell lung cancer.

Published: March 20th 2020 | Updated:

Published: April 7th 2020 | Updated:

Published: May 28th 2020 | Updated: